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Abstract
Background: Over diagnosis of malaria contributes to improper treatment, wastage of drugs and resistance to the few
available drugs. This paper attempts to estimate the rates of over diagnosis of malaria among children attending
dispensaries in rural Tanzania and examines the potential cost implications of improving the quality of diagnosis.
Methodology/Principal Findings: The magnitude of over diagnosis of malaria was estimated by comparing the proportion of
outpatient attendees of all ages clinically diagnosed as malaria to the proportion of attendees having a positive malaria rapid
diagnostic test over a two month period. Pattern of causes of illness observed in a ,2 year old cohort of children over one year
w a sc o m p a r e dt ot h ep a t t e r no fc a u s e so fi l l n e s si n,5 year old children recorded in the routine health care system during the
same period. Drug and diagnostic costs were modelled using local and international prices. Over diagnosis of malaria by the
routine outpatient care system compared to RDT confirmed cases of malaria was highest among ,5 year old children in the low
transmission site (RR 17.9, 95% CI 5.8–55.3) followed by the $5 year agegroup in the lower transmission site(RR 14.095%CI 8.2–
24.2). In the low transmission site the proportion of morbidity attributable to malaria was substantially lower in ,2y e a ro l d
cohort compared to children seen at routine care system. (0.08% vs 28.2%; p,0.001). A higher proportion of children were
diagnosed with ARI in the ,2 year old cohort compared to children seen at the routine care system ( 42% vs 26%; p,0.001).
Using a RDT reduced overall drug and diagnostic costs by 10% in the high transmission site and by 15% in the low transmission
site compared to total diagnostic and drug costs of treatment based on clinical judgment in routine health care system.
Implications: The introduction of RDTs is likely to lead to financial savings. However, improving diagnosis to one disease
may lead to over diagnosis of another illness. Quality improvement is complex but introducing RDTs for the diagnosis of
malaria is a good start.
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Introduction
Over diagnosis of malaria has been reported widely in both
outpatient [1] and inpatient [2] settings using syndromic diagnosis
[3] and with laboratory support [1,2]. This is one of the reasons for
the non recognition of thedecreasingmalariatransmission observed
in sub-Saharan Africa, particularly in East Africa [4,5], by global
estimates of disease burden [6,7], national statistics [8]and some
researchers [9]. Over diagnosis of malaria not only contributes to
the ‘‘scandal of ignorance of disease burden’’ but also to improper
treatment leading to drug wastage and resistance, inefficient use of
scarce resources, and most importantly poor health outcomes.
In Tanzania artemisinin-based combination therapy (ACT) is
the 1
st line treatment for malaria. Microscopy or rapid diagnostic
tests (RDTs) are used to confirm cases in health facilities that have
these resources [10]. In places where diagnostic equipment or
expertise is not available clinical diagnosis is the norm; this is a
common practice in many parts of Africa particularly in primary
health care facilities [11,12].
There is a growing debate about the cost effectiveness of
introducing RDTs in view of the adoption of expensive ACTs
[10,13,14,15,16,17] To date, costing and cost effectiveness models
have focused on the cost of malaria diagnosis and treatment
[15,17,18]. The few models that have estimated the costs of
treatment of non-malaria fever diagnoses have used the cost of an
antibiotic to represent this cost [10,16,19]. This paper attempts to
estimate the rates of over-diagnosis of malaria in eight government
health facilities in North-Eastern Tanzania and examines the
potential cost implications of improving the quality of diagnosis in
the context of a randomised controlled trial of different
antimalarials for the prevention of malaria in infants (IPTi) [20].
Methods
Study Sites
The study was conducted in a low and a moderate malaria
transmission area in Tanzania. The low transmission site, Same,
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8707located in Kilimanjaro region (Figure 1, is semi-arid, with altitude
ranging from 600m to 1000m in the plain and reaching up to
1900m in mountainous areas. Annual rainfall is low and seasonal,
the main rains falling between March and June (mean annual
rainfall 1996–2006 588ml range 265–1021ml). Incidence of malaria
was recorded as 0.018 per child per year in children aged 2–24
monthsofagebetween2005–2008 [20].Health facilitiesincludedin
the study were 1 district hospital in an urban setting (Same District
Hospital), 1 health centre (Ndungu) and 2 dispensaries (Kiswani and
Gonja Moare), situated in small rural townships.
The moderate transmission site, Korogwe District, Tanga
region (Figure 1) is situated in the coastal plain with an altitude
ranging from 200m to 600m. A small area of the district rises to
above 1500m. This area was reported as holoendemic for malaria
in 1991 [21] and has year round rainfall ranging from 800–
1400ml. Incidence of malaria was recorded as 0.31 per child per
year in children aged 2–24 months of age between 2005–2008
[20]. Health facilities included in the study in Korogwe were 1
peri-urban district hospital (Magnunga Hospital), 1 urban health
centre (Majengo) and 2 rural dispensaries (Magazin and Mnyusi).
Study Population for Estimating the Prevalence of
Malaria
The magnitude of the over diagnosis of malaria was estimated
by comparing data from 3 sources:
(i) Routine health information data. The causes of
morbidity among the outpatient attendees (all age groups) from
January to December 2007 were collected from the routine Health
Management Information System (HMIS) registers kept at each
health facility.
(ii) Health facility based cross sectional RDT
survey. This component of the study was done in July to
August 2007 in the 8 study health facilities. The study objectives
were explained to all outpatient attendees (all age groups)
requested to take part in the study. All patients attending for
any illness and giving written consent were checked for malaria
Figure 1. Study sites.
doi:10.1371/journal.pone.0008707.g001
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RDT results were reported to the health facility’s clinical staff for
making treatment decision.
(iii) Passive surveillance of causes of morbidity in a
cohort of children. Data on causes of morbidity in 2 months to
2 year-old children who were enrolled in the IPTi study (reported
elsewhere [20]) were collected through a passive surveillance
system at the 8 study health facilities. For this analysis the causes of
morbidity of children from the placebo groups from January to
December 2007 was obtained from the IPTi study database. The
IPTi study cohort was examined by study physicians on
presentation to a health facility in the study area and all
children with a history of fever were tested for malaria with an
RDT and expert microscopy. A case of malaria was diagnosed
only if the child had a history of fever in the previous 2 days or a
recorded fever in the presence of parasitaemia as determined by 2
research microscopists. However, children who had a positive
RDT were treated for malaria.
Costing
The cost of treatment of morbidity pattern in ,5 year old
children based on the HMIS data of the year of 2007(data source
(i) outlined above) was compared to that of the morbidity pattern
observed in the IPTi study cohort (data source (iii) outlined above).
The costing was undertaken from the perspective of the
government health system and focused on the costs of diagnostic
tools and drugs. Wider treatment costs to caretakers and providers
associated with inpatient and outpatient care were not included in
the analysis. Categories of cause of morbidity were based on those
listed in the HMIS data and these were: malaria, acute respiratory
infection, pneumonia, eye infection, ear infection, skin infections,
urinary tract infection and ‘other’ (other is a mean cost of all other
treatment groups). Treatment regimens and their associated costs
were based on recommended first and second line treatment for a
one year old infant weighing approximately 10kg, and the
proportion of children likely to receive the various drugs was
extrapolated from the prescribing practices of the study clinicians
from the IPTi study cohort. For example, to determine the average
unit cost of treating ARI, a weighted average was calculated to
reflect the type and frequency of all the drugs given to all children
identified and treated for ARI in the IPTi cohort. It was assumed
that extrapolating the unit costs of treating illnesses based on the
prescribing practices of the IPTi study clinicians would closely
mirror the prescribing practice advocated by national treatment
guidelines. Drug and diagnostic costs are modelled using local [22]
and where these were not available, international, prices [23] and
presented in 2007 US dollars.
The base case costing scenario assumed that in the IPTi study
cohort all suspected cases of malaria received an RDT at a unit
cost of US$0.75 [10] In the absence of data , it is assumed that
50% of all malaria diagnoses recorded in the HMIS data were
identified using microscopy at a unit cost of USD0.27 [10] and the
other 50% were treated presumptively. The cost of the ACT was
US$0.95 [22] for both cohorts.
Ethical Permission
Ethical permission was granted by the Ethical Review Boards of
the National Institute of Medical Research of Tanzania and the
London School of Hygiene and Tropical Medicine.
Data Analysis
The percentage of outpatient attendees who were RDT positive
and the percentage of attendees diagnosed as malaria in the HMIS
data over the 2 month study period (July and August 2007) were
compared in ,5 and $5 year old age groups. The distribution of
causes of morbidity in ,5 year old children reported in the
Routine Health care system data was compared to the distribution
of causes of morbidity in the placebo group of the IPTi study
cohort.
Potential cost savings by improving diagnosis were estimated by
comparing the cost of treatment of causes of morbidity in ,5 year
old children reported by the Routine Health care system to the
cost of treatment of morbidity observed in the placebo group of the
IPTi study cohort. Results are presented as total cost to the public
health care system (per 100 infants) and as ratio between IPTi
cohort costs versus Routine health care system costs. Univariate
sensitivity analysis was conducted on the main variables that were
uncertain, prone to change over time and cost drivers. Specifically,
the cost of the RDT was varied from US$1t oU S $0.50, ACT costs
from US$1t oU S $0.50 and the rate of routine microscopy use
from 100% to 0%.
Results
Over Diagnosis of Malaria
The comparison of the diagnosis of malaria confirmed by RDT
and diagnosed clinically at the study health facilities are shown in
Table 1. The magnitude of over diagnosis of malaria by the
routine outpatient care system compared to RDT confirmed cases
of malaria was highest among ,5 year old children in the low
transmission site (RR 17.9, 95% CI 5.8–55.3) followed by in the
$5 year age group in the lower transmission site (RR 14.0 95%CI
8.2–24.2). The over diagnosis of malaria by the routine care
system was high in the moderate transmission site as well though
the magnitude was relatively low compared to the low transmis-
sion site (RR 2.3, 95%CI 1.8–3.0 in ,5 year old children and RR
4.2, 95% CI 3.5–5.1 in $5 year age group).
In the low transmission site, the variation in the proportion of
patients having a RDT confirmed malaria did not vary
substantially between the health facilities; it ranged from 0 to
2% in ,5 year old children and 1–2% in $5 year old age group.
However, the clinical diagnosis of malaria varied dramatically
from 0–44% in ,5 year old children and 16–51% in $5 year age
group.
In the moderate transmission site, the variability in RDT
confirmed and clinically diagnosed malaria between the health
facilities was relatively low in both age groups except at Majengo
dispensary which serves an urban population. At this urban health
facility, the disparity between the RDT confirmed and clinically
diagnoses malaria was high in ,5 year old children (RR 5.6
95%CI 2.6–12.2) and in $5 years age group (RR 19.6 95%CI
8.9–43.2). The results from this urban dispensary are similar to
those from the low transmission site.
A comparison of the distribution of causes of morbidity in the
,2 year old children enrolled in the IPTi study cohort diagnosed
by study clinicians [20]and in the ,5 year old children in the same
health facilities diagnosed by routine health care providers in the
two sites in 2007 is shown in Table 2. In the low transmission site
the proportion of morbidity attributable to malaria was substan-
tially lower in the IPTi cohort compared to children seen at the
routine care system. (0.08% vs 28.2%; p,0.001). A higher
proportion of children were diagnosed with ARI in the IPTi
cohort compared to the children seen at the routine care system
( 42% vs 26%; p,0.001). More children were diagnosed with
urinary tract infection in the IPTi cohort than in the children seen
at the routine care system (19% vs 3%; p,0.001).
The same pattern was observed in the high transmission site. A
higher proportion of children were diagnosed with malaria in the
Improving Malaria Diagnosis
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IPTi cohort (44% vs 10%; p,0.001) and the proportion of
children with a diagnosis of ARI was lower in the routine care
compared to the IPTi cohort (18% vs 39%; p,0.001)
Drug and Diagnostic Costs
The unit costs of treating each causes of morbidity are shown in
Table 3. At US$1.92 and US$1.31 in the IPTi cohort and children
receiving routine care respectively, the unit cost of treating a child
with malaria was the most costly outpatient cause of morbidity to
treat.
The costs of treating each category of morbidity per 100
children based on the proportional morbidity in the IPTi cohort
and children treated at the routine care system is presented in
Table 4. In total costs, ARI was the most costly diagnostic category
in both transmission settings in the IPTi cohort, whereas malaria
was the most costly diagnostic category in both sites in the routine
care system. Using a RDT (as was done 100% of the time in the
IPTi study cohort) reduced overall drug and diagnostic costs by
10% in the high transmission site and by 15% in the low
transmission site, when compared to total diagnostic and drug
costs of treatment based on clinical judgment in the routine health
care system. This was largely due to the reduction in malaria
treatment costs by 66% and 99% in the moderate and low
transmission sites respectively when an RDT was used to guide
treatment compared to costs based on the clinical diagnosis of
malaria. The total treatment costs for ARI, skin infections and
UTI were notably higher in both transmission settings in the IPTi
cohort compared to the children treated in the routine care group.
The total costs of treating pneumonia were lower in the IPTi
cohort compared to routine care group.
Figure 2 shows the impact of changing the unit cost of a RDT
and ACTs, and the rate of routine microscopy. At the low
transmission site there was a 15% cost saving in the IPTi cohort
irrespective of RDT costs varying from US$1t oU S $0.50. This is
to be expected as very few outpatient cases (0.19%) were RDT
confirmed malaria. In the moderate transmission site, if RDTs
were used, the subsequent correct diagnosis and treatment of
children resulted in a 7 to 12% savings, when the cost of an RDT
is varied from US$1t oU S $ 0.50 respectively.
In the moderate transmission site, there were 7% savings to
15% additional costs if the cost of ACT varied from US$1t oU S $
0.50 per child treated respectively. The use of RDTs to improve
the accuracy of malaria diagnosis was only cost saving if ACTs cost
more than US$ 0.63. In the low transmission site, if the cost of
ACT varied from US$1t oU S $ 0.50 per child treated, there was a
17% savings to 7% additional costs respectively. RDTs were only
cost saving if ACTs were more than US$0.50.
The frequency of use of microscopy in routine care system had a
limited impact on cost savings. More importantly, however, even if
rates of microscopy use varied from 100% to 0%, the use of RDTs
in the IPTi cohort was always cost savings in both transmission
settings when compared to the routine care system. In the
moderate transmission setting, if microscopes were used 100% of
the time to diagnose malaria in routine care then the RDT group
showed 15% savings, if microscopes were never used, the IPTi
cohort showed 4% cost savings compared to routine care system.
In the low transmission settings the savings were between 19%
(100% microscopy use in routine care system ) and 11% (no
microscopy use).
Discussion
Over diagnosis of malaria occurs at high rates in both low and
moderate transmission settings. It is interesting to note that
although malaria is less common in the low transmission setting
and the risk ratio (RR) of over diagnosis is high, the actual
numbers of those wrongly diagnosed as having malaria is greater
in the moderate transmission setting as malaria is more frequently
diagnosed. This over diagnosis of malaria occurs largely at the
expense of under diagnosing ARI and pneumonia. This study
shows that in both study districts malaria is significantly over-
diagnosed at the primary health care level and that this over-
diagnosis is massive in low transmission areas as well as in small
urban settings (townships) such as district capitals in moderate
transmission areas. The high burden of malaria was observed
mostly in health facilities which were located in rural areas, and
this important difference has not been detected by the routine care
system. Rural communities bear the brunt of malaria burden.
However, due to growing townships in rural areas this population
at risk of malaria is decreasing. The population in small townships
Table 2. Comparison of causes of morbidity in ,2 year old children in the IPTi study cohort and in ,5 old children seen in the
routine heath care system in 2007 in the study health facilities.
Diagnosis KOROGWE (Moderate transmission site) SAME (Low transmission site)
IPTi cohort Routine health care system IPTi cohort Routine health care system
%N%N % N % N
MALARIA 9.8 147 44.3 6640 0.1 1 28.2 4679
ARI 39.4 592 18.4 2756 41.7 502 26.3 4261
PNEUMONIA 6.9 104 11.8 1768 8.7 105 14.4 2333
DIARRHOEA 9.2 138 6.7 1011 14.4 173 13.4 2163
EYE INFECTIONS 2.6 39 1.6 239 3.2 38 1.9 310
EAR INFECTIONS 1.2 18 1.4 215 1.5 18 0.9 143
SKIN INFECTIONS 9.2 138 3.1 461 7.7 93 1.6 315
UTI 14.9 224 8.3 1242 18.9 227 3.0 480
OTHER 7.0 105 4.4 656 3.9 47 0.7 118
TOTAL 100.0 1503 100.0 14988 100.0 1204 100.0 16184
doi:10.1371/journal.pone.0008707.t002
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housing, access to health care, access to education, higher
population density and decreased malaria transmission [24].
Over diagnosis is costly in physical and financial terms. The
physical cost is in people who are ill due to a cause other than
malaria and not getting the appropriate treatment leading to
severe disease and mortality [2]. Financially children that are
misdiagnosed are likely to require subsequent consultations and
receive additional treatment that may require more expensive
drugs and inpatient care. This increases costs to both the
households [25,26]and health care providers [27]. We have
shown that by improving the quality of diagnosis the burden of
malaria is being reduced as non malaria illness are better
diagnosed and treated, simply by improving accuracy, and an
overall benefit on morbidity and mortality is possible. However
there is a need to equip health facilities with important and simple
diagnostic equipments in order to facilitate improvements in
clinical care. In the IPTi study cohort 15%–20% of the children
who attended a study health facility were diagnosed as having
urinary tract infections. This is most probably a further over
diagnosis of another cause of morbidity and relates to what
clinicians do when they can no longer use malaria as a ‘catch all’
diagnosis. The next step in this case would be to introduce urine
dipstick analysis. However, this would mean additional investment
to the health infrastructure such as sterile pots to collect urine, a
fridge to store the reagent strips, training in their use, etc., which
would lead to additional costs.
Our cost analysis suggests that there is a thresholds where the
price of an infant dose of ACT no longer makes RDT use cost
saving. In the low transmission setting this is US$ 0.50 and in the
moderate transmission setting this is US$ 0.63. If, however, the
cost of ACT was to remain at US$0.95, even if the cost of the
RDT were to increase to US$1 RDTs would still be cost saving.
Regardless of the level of microscopy use in routine practice, RDT
use would always be cost saving in both transmission settings. This
is likely to be due to the low quality of routine microscopy [28] ,
the relatively easier interpretation of RDT results than reading a
blood slide and less dependent on technical skills and resources. It
is important to note, however, that we talk about ‘cost saving’ in
terms of drugs and diagnostic costs only. If this cost analysis was
broadened to include the cost implications of incorrect diagnoses
incurred at both the household and health system level the
Table 3. Costing assumptions.
Categories of causes
of morbidity and
Drugs Prescribed
Estimated
Proportion
of children
receiving this
prescription
Cost of treatment
per category of
morbidity per
child (US $ 2007)
Malaria 1.92
a
1.31
b
(ALU) COARTEM 100%
Paracetamol 100%
RDT (IPTi group) 100%
Microscopy
(HMIS/routine group)
50%
ARI 0.59
AMOXYCILINE SYRUP 76%
Cotrimoxazole Syrup 11%
Erythromycin Syrup 6%
Chloromphenical 7%
COUGH SYRUP 78%
Paracetamol 44%
Pneumonia 0.90
AMPICILLIN/GENTER 100%
Diarrhoea 1.02
ORS 100%
Ringer lactate intravenous fluid100%
Cotrimoxazole 48%
Erythromycin 13%
Amoxycillin 9%
Ceftriaxone 6%
Ampicillin and gentamycin
injection
24%
Gastroenteritis 0.56
ORS 100%
Erythromycin Tabs 61%
Ampicillin injection and
gentamycin injection
8%
Cotrimoxazole Syrup 22%
Amoxycillin syrup 6%
Metronidazole Syrup 3%
Eye Infection 0.72
Tetracycline eye ointment 100%
Ear Infection 0.86
Amoxycillin syrup 34%
ampiclox syrup 74%
Erythromycin Syrup 6%
Boric acid/gentamycin ear
drops
81%
Skin Infections 0.92
G.V PAINT 54%
Cloxacillin syrup 67%
Ampiclox syrup 33%
Urinary Tract Infection 0.53
Amoxycillin syrup 61%
Chloromphenical 11%
Categories of causes
of morbidity and
Drugs Prescribed
Estimated
Proportion
of children
receiving this
prescription
Cost of treatment
per category of
morbidity per
child (US $ 2007)
Ampicillin injection and
gentamycin injection
18%
Erythromycin 4%
Cotrimoxazole 6%
Paracetamol 100%
Other 0.89
Cost per infant is an average of
other intervention costs
aCost per infant – IPTi Cohort (all suspected cases of malaria received an RDT).
bCost per infant routine health system (50% of all malaria diagnoses identified
using a microscopy and the other 50% were treated presumptively).
doi:10.1371/journal.pone.0008707.t003
Table 3. Cont.
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perspective even if the unit cost of an RDT was to increase beyond
the thresholds identified here.
We have looked at the cost implications of using RDTs to better
identify malaria episodes and in addition the costs associated with
treating a range of non malaria illness episodes. The paper does
not undertake a rigorous cost effectiveness analysis [10,18] or cost
benefit analysis [14] as seen elsewhere, therefore it would be
inaccurate to compare the cost of this paper directly with analysis
undertaken in other studies. However, certain findings in this
study are supported by economic evaluations modelled elsewhere.
Other models have demonstrated that locations where RDT use is
preferable is dependent on factors such as malaria transmission
intensity and the costs and accuracies of the RDTs under
consideration [13].
In southern Mozambique the use of RDTs in all suspected cases
of malaria was shown to be cost-saving when parasite prevalence
among clinically diagnosed malaria cases was low to moderate.
However, the study also suggested that targeting RDTs at the
group older than 5 years and treating children less than 5 years on
the basis of clinical diagnosis was even more cost-saving [17]. A
model developed to illustrate the use of the two main classes of
RDTs in the Ugandan context demonstrated that if only direct
expenditures are considered, the pLDH test is the preferred option
for adult patients except in high transmission settings, while young
children are best treated presumptively in all settings. When health
outcomes were considered, the HRP2 test gained an advantage in
almost all settings and for all age groups [13]. A cost benefit study
conducted in north-eastern Tanzania found that at high and low
levels of malaria transmission, rapid diagnostic tests were more
cost beneficial than microscopy, and both more so than
presumptive treatment, but only where a clinicians prescribing
response was consistent with test results [14]. The importance of
health care provider behaviour in relation to test results was also
found to greatly influence cost savings in Zambia [18] and
Southern Mozambique. It is important to better understand the
behaviour of health workers when using RDTs as they do not
always comply with results, even if true negative [29] and this has
cost implications [12].
Limitations
The paper uses data from different sources and although we
make direct comparisons, readers should consider the extrapola-
tions that we have made. There are certain limitations when
making comparisons between Routine Health care system and
RDT survey data, as the Routine Health care system data contains
the same people who are sampled in the RDT survey and the
Routine Health care system data is known to be incomplete as not
all attendees would have been registered. However, the Routine
Health care system data is used for government statistics and its
weaknesses have to be acknowledged and accepted [30]. When
comparing the IPTi study cohort with the Routine Health care
system, there is an age difference between comparison groups as
the IPTi study cohort were under 2 years of age while the Routine
Health care system included children ,5 years. Children under 2
years are more likely to have more sickness than the under 5’s and
Figure 2. Sensitivity Analysis on cost implications. Figure 2a:
Cost Implications on Changing the Cost of RDTs. Figure 2b: Cost
Implications on Changing the Cost of ACT. Figure 2c: Cost Implications
on Changing the Rates of Routine Microscopy.
doi:10.1371/journal.pone.0008707.g002
Table 4. Drug and diagnostic costs (per 100 infants treated).
Costs KOROGWE SAME
(Moderate transmission site) (Low transmission site)
IPTi Cohort Routine Health Care
1 Cost Comparison* IPTi Cohort Routine Health Care Cost Comparison
Total Costs Total Costs Total Costs Total Costs
MALARIA 18.85 57.95 33% 0.19 36.89 1%
ARI 23.38 10.92 214% 24.74 15.61 159%
PNEUMONIA 6.21 10.62 58% 7.83 12.96 60%
DIARRHOEA 9.39 6.84 137% 14.70 13.68 107%
EYE INFECTIONS 1.86 1.14 163% 2.29 1.36 168%
EAR INFECTIONS 1.03 1.20 86% 1.28 0.77 167%
SKIN INFECTIONS 8.49 2.86 297% 7.10 1.48 481%
UTI 14.90 4.38 340% 9.98 1.58 630%
OTHER 6.24 3.92 159% 3.90 0.62 625%
TOTAL 90.34 99.83 90% 72.03 84.95 85%
1Routine Health Care represents data from HMIS.
*IPTi cohort costs/Routine health care system costs.
doi:10.1371/journal.pone.0008707.t004
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possibility of having a trial effect in the IPTi study cohort. The
IPTi study cohort (albeit placebo group) may have had less serious
cases as they may have had different health seeking behaviour as
they were encouraged to attend at the health facilities in the
presence of any symptom. However, we have given an
approximation of the likely proportions of disease burden that
routine health care systems in rural districts in Tanzania faced in
2007. This will allow policy makers to readjust their assumptions
on malaria burden and to understand that establishing disease
burden is a moving target and requires more attention.
The costing part has its limitations. Most notably, we do not
consider the effect of variability in the specificity and sensitivity of
RDTs on the cost savings. The sensitivity and specificity of RDTs
is reported to be 90% and 95% respectively compared with expert
slide reading [1,31,32]. We assume that the sensitivity and
specificity would be 100% for both RDTs and microscopy for
the cost analysis. While we acknowledge the potential limited
accuracy of some RDTs, particularly the low sensitivity of some
RDTs, this is not incorporated into our analysis. It should be noted
however, that given the low prevalence of malaria in both the
study settings, the actual number of false negatives is likely to be
extremely low, compared to the number of false positives in
routine clinical diagnosis and the difference will continue to
increase where malaria prevalence is falling. We also assume that
the clinician prescribes on the basis of the test results. Previous
research in Tanzania suggests this has not always been true in
practice [29,33]. Our costing perspective does not include the
added saving from averting inpatient care, both from malaria and
other causes of illness nor account for the added costs of false
diagnosis. The costs are from the perspective of government
funded health facilities. A previous study conducted in north-
eastern Tanzania showed only 45% of under fives seeking care in
these type of facilities (unpublished data). The cost savings from
slowing drug resistance are outside the remit of the study [34]
In both the RDT survey and the IPTi study cohort [20], the
prevalence of malaria was much higher in the two health facilities
which were located in the rural areas compared to those located in
small towns. In the HMIS report this was not observed and showed
an equal distribution malaria cases in all the health facilities. Burden
estimates tend to be based on extrapolation of prevalence of malaria
observed in research sites to whole districts and where no
information exists, from a nearby district [6]. This study highlights
that even in areas of moderate transmission; estimates of malaria
burden will be biased if it is assumed that the small townships have
the same malaria risk as the rural populations.
There has been a decrease in malaria across the region which
national statistics and clinical diagnoses have not reflected. In this
paper we show that improving accuracy of diagnosis by using
RDTs and with the benefit of continuous supervision by a
research team, similar to continuous medical education (CME)
widely adopted in developed countries, over diagnosis of malaria
can be detected and appropriate treatments can be given to
patients. RDT testing should be implemented nationally and a
record of RDT positive diagnoses fed back to the National
Malaria Control Program, where control activities could focus on
the places where malaria is truly a problem. Health education
about malaria and the alternative diagnoses needs to be directed
at clinicians and in a more general way to the general population.
The extent to which RDTs are cost saving will be associated with
the frequency of their use. If the practice of over diagnosis of
malaria is widespread, an initial over use of RDTs can be
expected, which will carry additional costs. Overtime however,
the frequency of true negative readings should go a long way to
reassure health care providers and the general population that the
prominence given to malaria is unfounded, and therefore RDT
use in general should fall. Currently supervisory visits focus on
preventive services especially EPI and more recently IMCI. We
suggest that these visits should be broader and include supervision
on curative services for all age groups and focus on improving
diagnosis. This study sheds some light on what diagnoses health
services should expect and suggests that respiratory tract disease
and diarrhoea are still major causes of morbidity in Africa even in
areas of high transmission of malaria.
Policy Implications
Malaria transmission differs enormously throughout Tanzania
[35] with the majority of the country being moderate and low
transmission. Thus the introduction of RDTs is likely to lead to
financial savings. However, improving diagnosis to one disease
may lead to over diagnosis of another illness, in this case urinary
tract infections; highlighting the need for ever more complex
diagnostic and health services. Quality improvement is complex
but introducing RDTs for the diagnosis of malaria is a good start.
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